[SCHEDULE 13G] DENTSPLY SIRONA Inc. SEC Filing

Rhea-AI Filing Summary

Lazard Asset Management LLC filed a Schedule 13G reporting ownership of 10,107,657 shares of DENTSPLY SIRONA Inc. (CUSIP 24906P109), representing 5.1% of the outstanding equity as of 06/30/2025. The filer reports sole voting power over 10,002,455 shares and sole dispositive power over 10,107,657 shares. The filing identifies the reporting person as an investment adviser (IA) organized in New York and includes a certification that the securities are not held to change or influence control of the issuer. The filing is signed by Mark Anderson, Managing Director, General Counsel, dated 08/14/2025.

Positive

• Material disclosure: Ownership exceeds 5% (10,107,657 shares), meeting SEC thresholds for investor visibility
• Clear control attributes: Reporting of sole voting (10,002,455) and sole dispositive power (10,107,657) clarifies internal authority over the position
• Filing classification: Submitted under Schedule 13G as an investment adviser (IA), indicating passive intent rather than a control-seeking acquisition
• Certification provided: Explicit statement that shares are not held to change or influence control of the issuer

Negative

• None.

Insights

Financial Analyst

TL;DR: Lazard Asset Management now holds a material 5.1% stake in DENTSPLY SIRONA, indicating meaningful passive institutional ownership.

The Schedule 13G shows Lazard as an investment adviser with 10.1 million shares (5.1%), reporting sole voting and dispositive power over the majority of its stake. Because this is a 13G (not 13D) and the filing includes a certification that the position is not intended to influence control, the disclosure signals a sizable, likely passive, institutional position rather than an activist stake. Investors should note the exact voting and dispositive counts which confirm centralized portfolio control within Lazard.

Corporate Governance Expert

TL;DR: A >5% disclosure via Schedule 13G highlights material ownership but affirms no intent to seek control, consistent with passive investor behavior.

The filer’s classification as an investment adviser and the explicit certification against seeking control align with Schedule 13G filing norms for passive investors. The limited shared voting/dispositive power (reported at zero) suggests internal centralized decision-making at Lazard for these shares. From a governance perspective, a single institutional holder at this level can still influence outcomes through routine engagement, though this filing does not indicate activist intentions.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

DENTSPLY SIRONA Inc

(Name of Issuer)

Equity

(Title of Class of Securities)

24906P109

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 24906P109

1

Names of Reporting Persons

Lazard Asset Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 10,002,455.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,107,657.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,107,657.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: DENTSPLY SIRONA Inc
(b)	Address of issuer's principal executive offices: 13220-B Ballantyne Corporate Place, Charlotte, US-NC, 28277, US
Item 2.
(a)	Name of person filing: Lazard Asset Management LLC
(b)	Address or principal business office or, if none, residence: 30 Rockefeller Plaza, New York, 10112, NY, United States
(c)	Citizenship: NEW YORK
(d)	Title of class of securities: Equity
(e)	CUSIP No.: 24906P109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 10,107,657
(b)	Percent of class: 5.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 10002455
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 10,107,657
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lazard Asset Management LLC

Signature:	Mark Anderson
Name/Title:	Managing Director, General Counsel
Date:	08/14/2025

FAQ

What percentage of DENTSPLY SIRONA (XRAY) does Lazard Asset Management own?

The filing reports 10,107,657 shares, representing 5.1% of the class as of 06/30/2025.

Does Lazard Asset Management have voting control over its XRAY shares?

Yes. The filer reports sole voting power over 10,002,455 shares and sole dispositive power over 10,107,657 shares.

Is this filing a Schedule 13G or 13D and what does that imply?

This is a Schedule 13G filed by an investment adviser (IA), which typically indicates a passive investment with no intent to change or influence control.

When was the Schedule 13G signed and who signed it?

The filing is signed by Mark Anderson, Managing Director, General Counsel, dated 08/14/2025.

Where is Lazard Asset Management organized and where is the issuer located?

Lazard Asset Management LLC is organized in New York; DENTSPLY SIRONA's principal executive offices are listed in Charlotte, North Carolina.